Janus Henderson Group’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$401M Buy
9,276,532
+2,105,133
+29% +$90.9M 0.2% 116
2025
Q1
$252M Buy
7,171,399
+2,263,866
+46% +$79.5M 0.14% 164
2024
Q4
$135M Buy
4,907,533
+89,521
+2% +$2.46M 0.07% 242
2024
Q3
$123M Buy
4,818,012
+505,481
+12% +$12.9M 0.06% 250
2024
Q2
$109M Buy
4,312,531
+999,825
+30% +$25.3M 0.06% 252
2024
Q1
$102M Buy
3,312,706
+2,169,143
+190% +$67.1M 0.06% 262
2023
Q4
$46.2M Sell
1,143,563
-50
-0% -$2.02K 0.03% 390
2023
Q3
$30.2M Buy
1,143,613
+1,100,120
+2,529% +$29M 0.02% 457
2023
Q2
$748K Sell
43,493
-60,975
-58% -$1.05M ﹤0.01% 1751
2023
Q1
$1.73M Buy
104,468
+90,640
+655% +$1.5M ﹤0.01% 1342
2022
Q4
$105K Sell
13,828
-13,830
-50% -$105K ﹤0.01% 2325
2022
Q3
$274K Buy
27,658
+13,592
+97% +$135K ﹤0.01% 2254
2022
Q2
$128K Buy
14,066
+218
+2% +$1.98K ﹤0.01% 2431
2022
Q1
$141K Sell
13,848
-14
-0.1% -$143 ﹤0.01% 2510
2021
Q4
$231K Sell
13,862
-2,631,579
-99% -$43.9M ﹤0.01% 2326
2021
Q3
$124M Sell
2,645,441
-165,211
-6% -$7.74M 0.05% 324
2021
Q2
$171M Sell
2,810,652
-62,531
-2% -$3.81M 0.07% 270
2021
Q1
$177M Buy
2,873,183
+1,089,648
+61% +$67.1M 0.08% 242
2020
Q4
$127M Buy
1,783,535
+92,074
+5% +$6.55M 0.06% 312
2020
Q3
$63.5M Sell
1,691,461
-74,403
-4% -$2.79M 0.03% 439
2020
Q2
$57.6M Sell
1,765,864
-20,175
-1% -$658K 0.03% 454
2020
Q1
$51.8M Sell
1,786,039
-1,355,042
-43% -$39.3M 0.04% 448
2019
Q4
$110M Buy
3,141,081
+2,688,910
+595% +$94.2M 0.06% 340
2019
Q3
$9.71M Buy
452,171
+106,182
+31% +$2.28M 0.01% 954
2019
Q2
$9.33M Buy
+345,989
New +$9.33M 0.01% 960